Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epclusa in HCV-mismatched Kidney Transplant
NCT03809533Phase 2Active, not recruiting
- Start
- May 2019
- Primary completion
- Apr 2026
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of velpatasvir in hepatitis C (HCV). Started May 2019; status: active, not recruiting.
02
Drugs
velpatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03809533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809533.